Benitec Biopharma Inc. Reports Net Loss of $4.4 Million in Q1 2023

Benitec Biopharma Inc., (BNTC) a leading biotechnology company , has released its consolidated financial statements for the first quarter of 2023. The company reported a net loss of $4.4 million for the quarter. However, it generated $54,000 in revenue during the same period. Let's take a closer look at the financial performance of Benitec Biopharma Inc. in Q1 2023.

Financial Performance

Benitec Biopharma Inc. experienced a net loss of $4.4 million in the first quarter of 2023. This represents a decrease compared to the net loss of $3.3 million reported in the same quarter last year. Despite the loss, the company managed to generate $54,000 in revenue during the quarter, slightly higher than the $48,000 generated in the first quarter of the previous year.

Consolidated Balance Sheets